CIBIC +

Related by string. * : CIBIC plus . CIBIC Plus / + - [008] . + - [003] . + - [027] . + - [020] . + - [007] . + - [017] . + - [022] . + - [001] . + - [019] . - + [007] . - + [012] . + - [016] . - + [003] : + S europe . Average + -1 . Crispin Porter + Bogusky . + input switcher . diagnosed Ph + . assigned BBB + . Ph + CML . Ph + ALL . BOWE BELL + HOWELL . Wieden + Kennedy . + #.#s [002] . + Podcasting Voices * *

Related by context. All words. (Click for frequent words.) 64 Neuropsychiatric Inventory NPI 63 CIBIC plus 62 Clinician Interview Based 62 ADCS CGIC 61 ADAS Cog 61 Main Outcome Measure 60 ADAS cog 60 CIBIC Plus 60 premorbid 59 Main Outcome Measures 59 ADCS ADL 59 WOMAC pain 57 Alzheimer Disease Assessment 57 EORTC QLQ C# 57 empirically validated 57 SF #v# 57 haemodynamic 57 convergent validity 57 psychophysiological 57 symptom severity 57 Visual Analogue Scale VAS 56 Secondary endpoints include 56 Outcome Measures 56 Primary endpoints 56 comorbid anxiety 56 NIH CPSI 56 cardiac autonomic 56 Brief Psychiatric 56 Neuropsychiatric Inventory 56 CORE OM 56 Global Impression CGI 56 cognitive affective 56 Secondary endpoints included 56 neuropsychological assessment 56 HRQoL 55 syndromic 55 Montgomery Asberg Depression 55 psychosocial variables 55 sociodemographic characteristics 55 Health Assessment Questionnaire 55 covariate 55 posttransplant 55 BPS IC 55 anthropometric measures 55 CFQ R 55 Scale PANSS 55 psychosocial functioning 55 HAQ DI 55 mean ± SEM 55 endometrial thickness 55 EQ 5D 55 multiple linear regression 55 Scale cognitive subscale 55 neuritic 54 subscale scores 54 intraclass correlation coefficients 54 pharmacodynamic parameters 54 Severity MSCS score 54 Anthropometric 54 Distress Scale 54 neurocognitive function 54 SELENA SLEDAI 54 generalized estimating 54 noncognitive 54 Pain Intensity 54 Rating Scale UPDRS 54 posttest 54 Histologic 54 hemodynamic measurements 54 Cognitive behavioral 54 CONCERTA ® 54 Tasigna prolongs 54 left ventricular diastolic 54 biopsychosocial 54 CT urography 54 sociodemographics 54 Status Scale EDSS 54 interrater reliability 54 Mean Symptom Complex 54 Negative Symptoms 53 affective psychosis 53 interobserver 53 HRQOL 53 erection hardness 53 Treatment Outcome 53 electrophysiologic 53 PCWP 53 pharmacodynamic PD 53 hematologic parameters 53 neurosensory 53 Socio demographic 53 neurobehavioural 53 visuomotor 53 predictive validity 53 logistic regression model 53 ANCOVA 53 carotid IMT 53 venous thromboembolic disease 53 posttreatment 53 BMI z 53 ALSFRS R 53 waist circumference WC 53 Sociodemographic 53 antioxidant supplementation 53 logistic regression analyzes 53 PANSS 53 psychoeducation 53 Echocardiographic 53 NNT = 53 actigraphy 53 APOE genotype 53 HAM D 53 Fibromyalgia Impact Questionnaire 53 Randomized controlled 53 nonpharmacologic 53 neurocognitive functioning 53 postdischarge 53 MADRS score 53 NIHSS score 53 neuropsychological functioning 52 Unified Parkinson Disease 52 Assessment Questionnaire 52 Symptom severity 52 guideline concordant 52 CI -#.# 52 UPDRS Part III 52 6MWD 52 HRQL 52 comorbid disorders 52 poststroke 52 demonstrated clinically meaningful 52 neuropsychological assessments 52 hematological parameters 52 anthropometric 52 Seattle Angina Questionnaire 52 cerebral oxygenation 52 ADHD Rating Scale 52 morphologic characteristics 52 pretransplant 52 corneal curvature 52 Skin sterol 52 electroencephalographic 52 subscales 52 metabolite concentrations 52 subscores 52 Montgomery Åsberg Depression 52 diffusion tensor 52 Score DAS 52 BEXXAR Therapeutic Regimen 52 International Prostate Symptom 52 neuropsychological 52 schizophreniform disorder 52 parkinsonian 52 Ocular Surface Disease 52 sociodemographic factors 52 cystoscopic 52 linear regression analyzes 52 intact parathyroid hormone 52 bispectral index BIS 52 meta analytic 52 RNFL thickness 52 HOMA IR 52 p = .# [002] 52 Rating Scale BPRS 52 IntroductionThe 52 fructosamine 52 meta analytic review 52 neurocognition 52 bioprosthetic valve 52 statistically significant p = 52 Cardiorespiratory fitness 52 affective psychoses 52 subscore 52 Wechsler Adult 52 Oswestry Disability Index 52 postintervention 52 serum lipid 52 plus octreotide LAR 52 clinicopathological features 52 neuropsychological deficits 52 behaviourial 52 Secondary endpoints 51 familial clustering 51 NIHSS 51 Multivariate logistic regression 51 prospective multicentre 51 diabetic polyneuropathy 51 meta regression 51 conditional logistic regression 51 micronutrient supplementation 51 poststroke depression 51 urodynamic 51 mortality morbidity 51 psycho physiological 51 eNO 51 Severity Index 51 Cronbach alpha 51 intima media thickness IMT 51 Multiple linear regression 51 Quantitative EEG 51 Univariate analysis 51 ANOVA 51 Symptom Checklist 51 adenotonsillectomy 51 QoL 51 YMRS 51 Erectile Function IIEF 51 Score IPSS 51 Modifiable 51 odds ratios ORs 51 perfusion abnormalities 51 nonepileptic seizures 51 bivariate 51 Child Behavior Checklist 51 Scale Cognitive Subscale 51 daytime somnolence 51 Secondary efficacy endpoints 51 Pharmacodynamic 51 ALS Functional 51 Comorbidity 51 Lewy bodies DLB 51 Rating Scale MADRS 51 intraclass correlation coefficient 51 Insulin sensitivity 51 accelerometry 51 clinicopathological 51 logistic regression analysis 51 polysomnographic 51 urodynamic studies 51 sacral neuromodulation 51 physiological nutritional 51 statistically significant correlation 51 extrapyramidal symptoms 51 Outcomes Study 51 liver histology 51 insulin resistance HOMA IR 51 clinically meaningful improvement 51 peak VO2 51 Poisson regression 51 RNFL 51 multiple logistic regression 51 neurocognitive outcomes 51 HRCT 51 bronchial hyperresponsiveness 51 Functional Assessment 51 Univariate 51 intraobserver 51 Abnormal Involuntary Movement 51 pre operatively 51 androgen depletion 51 Global Impression 50 Postoperatively 50 explanatory variables 50 pharmacodynamic endpoints 50 carotid artery intima media 50 plasma lipid 50 dichotomized 50 Histopathologic 50 retinal nerve 50 psychometric properties 50 biobehavioral 50 audiometric 50 UPDRS scores 50 interobserver reliability 50 histologic findings 50 carotid intima media 50 DLQI 50 PDSS 50 Psychodynamic 50 postural sway 50 scintigraphic 50 SGRQ 50 histologic 50 psychoeducational 50 nonsignificant 50 Quantifiable 50 neurophysiologic 50 intima media thickness 50 morphometric 50 WOMAC 50 serum BDNF 50 mitral annular 50 Coronary CTA 50 daytime alertness 50 Cystic Fibrosis Questionnaire Revised 50 Polysomnography 50 sociodemographic variables 50 chi squared 50 multivariate regression 50 peripheral insulin sensitivity 50 Score DAS# 50 logistic regressions 50 immunohistochemical 50 endophenotypes 50 multivariable adjusted 50 neurobehavioral 50 etiologic 50 neuropathological 50 prespecified secondary 50 CPAP adherence 50 nasal symptom 50 fasting insulin 50 overnight polysomnography 50 transcranial Doppler ultrasound 50 Alzheimer Disease Cooperative 50 STRIDE PD 50 microvessel 50 laterality 50 FACIT 50 emotional dysregulation 50 = #.#-#.# 50 Edinburgh Postnatal Depression 50 aspartate aminotransferase AST 50 neurobehavioral functioning 50 reactive hyperemia 50 BMI waist circumference 50 Pearson correlation coefficient 50 central corneal thickness 50 urine albumin 50 lipid profiles 50 Index CDAI 50 nonrandom 50 Postural 50 polysomnogram 50 extraocular 50 urodynamic parameters 50 PLMs 50 Hazard Ratio HR 50 fractional anisotropy 50 interpretability 50 MMSE 50 perceptual reasoning 50 NHAMCS 50 atherothrombotic 50 glucose homeostasis 50 cerebral ischemic 50 prospectively stratified 50 confidence interval CI 50 Crohn Disease Activity 50 estimated glomerular filtration 50 clinically meaningful improvements 50 Attention-Deficit/Hyperactivity Disorder ADHD 50 echocardiographic 50 posterior cingulate 50 schizophrenia schizoaffective disorder 50 COMT genotype 50 MADRS 50 axial length 50 microstructural 50 preoperative intraoperative 49 depressive symptom 49 plasma cortisol 49 Neuropsychological 49 euthymic patients 49 logistic regression 49 pretreatment serum 49 Lower Limb 49 Psoriasis Area 49 State Examination MMSE 49 perseverative 49 Depressive Symptoms 49 Geriatric Depression 49 Visual Analog 49 genomewide 49 risk reducing salpingo 49 df = 49 maturational 49 fasting plasma 49 UPDRS 49 clinically relevant 49 adverse perinatal 49 treat NNT 49 Electrophysiological 49 methacholine challenge 49 postop 49 Histological 49 neuroleptic 49 hyperactivity inattention 49 Visual Analog Scale 49 IRLS 49 ± SEM 49 Pearson correlation coefficients 49 perfusion defect 49 multivariable logistic regression 49 multivariable analysis 49 transabdominal 49 anxiety suspiciousness 49 CIMZIA TM certolizumab pegol 49 viral tropism 49 suicide ideation 49 cluster randomized controlled 49 methotrexate monotherapy 49 Visual acuity 49 adenoidectomy 49 medial frontal cortex 49 HEDIS R 49 anthropometric measurements 49 multivariable Cox 49 extramedullary 49 intestinal permeability 49 alexithymia 49 Neurocognitive 49 MMSE score 49 BPRS 49 GH deficiency 49 Pelvic Organ Prolapse 49 WOMAC scores 49 Score TOS 49 albumin excretion rate 49 CINQUIL 49 MDRD 49 radiotracer uptake 49 Viral load 49 chronicity 49 ski lls 49 inattention hyperactivity 49 PSQI 49 subjective sleepiness 49 attain statistical significance 49 pulmonary artery banding 49 airway hyperresponsiveness 49 MATRICS 49 HAM D# 49 antibody titer 49 amisulpride 49 serum lipid levels 49 Negative Syndrome 49 clinical meaningfulness 49 arterial oxygen saturation 49 subthreshold depression 49 semiquantitative 49 Pain Rating Scale 49 exploratory endpoints 49 univariate analyzes 49 preterm neonates 49 estimated GFR 49 neurocognitive deficits 49 prospective observational studies 49 Pharmacokinetic 49 HbA1C levels 49 creatinine ratio 49 neurocognitive 49 neuropsychiatric symptoms 49 retest reliability 49 nonpsychotic 49 Endothelial function 49 nasal airflow 49 aMCI precursor 49 Severity Index PASI 49 multivariate logistic regression 49 salivary cortisol 49 Mammographic 49 % CI #.#-#.# [008] 49 Fecal Incontinence 49 β = 49 pupillary 49 atherosclerotic renal artery stenosis 49 Mantel Haenszel 49 nonparametric 49 Hamilton Rating Scale 49 Rating Scale 49 semistructured interview 49 hepatic lesions 49 exhaled nitric oxide eNO 49 multivariate Cox 49 Individualised 49 Project SCIP 49 electroencephalograms 49 MDCT scans 49 retinal thickness 49 Preoperative 49 spirometric 49 chemometrics 49 mania hypomania 49 allergen avoidance 49 glaucomatous 49 blinded randomized controlled 49 Logistic regression 49 TF CBT 49 neurocognitive dysfunction 49 postoperative AF 49 anticholinergic agents 49 SSRI citalopram 49 sd = 49 dietary modification 49 observable characteristics 49 electrophysiological 49 Assessment Scale 49 depression suicidal ideation 48 lipid parameters 48 neural correlates 48 psychopathological symptoms 48 glycosylated hemoglobin levels 48 LV dysfunction 48 comorbid psychiatric 48 Lumbar spine 48 affective disorders 48 renal scarring 48 confounder 48 Multivariable 48 neuroanatomical 48 DAS# scores 48 pulsed Doppler 48 serum markers 48 Prognostic 48 statistically significant predictor 48 PANSS Positive 48 acoustic startle 48 inferential statistics 48 tissue oxygenation 48 Logistic regression analysis 48 postprocedure 48 QTc intervals 48 colonoscopic 48 antenatal depression 48 frameless radiosurgery 48 correlation coefficients 48 surgically induced 48 clinically meaningful reductions 48 erythrocyte sedimentation rate 48 emotional lability 48 euthymic 48 antiretroviral naïve 48 Suicidal ideation 48 Reproducibility 48 tryptophan depletion 48 IPSS 48 interrater 48 echocardiographic parameters 48 PIB PET 48 genotypic resistance 48 neuropsychological impairments 48 HADS 48 Likert 48 predisposing factor 48 achieved statistical significance 48 perioperative complications 48 bone metabolism 48 comorbid psychiatric disorders 48 causal pathway 48 PROMs 48 PROactive study 48 PANSS scores 48 EEG recordings 48 induced sputum 48 prospectively defined 48 Hamilton Anxiety Scale 48 Subgroup analyzes 48 schizophreniform 48 Multiple logistic regression 48 AST ALT 48 elective percutaneous coronary 48 Descriptive statistics 48 anterior temporal 48 logistic regression models 48 psychiatric morbidity 48 methodologic 48 QIDS SR 48 observational cohort 48 morphometric vertebral fractures 48 DAS# CRP 48 plasma lipids 48 lymphocyte subsets 48 -#.# ± [002] 48 #q# deletion syndrome 48 virologic responses 48 Hepatotoxicity 48 TOP2A gene 48 attention-deficit/hyperactivity 48 spatio temporal 48 electron beam computed tomography 48 differential gene expression 48 Clinically meaningful 48 highly heritable 48 postural stability 48 autonomic dysfunction 48 stimulated insulin secretion 48 enthesitis 48 psychodynamic therapy 48 generalisable 48 allele frequencies 48 HDRS 48 shorter telomere length 48 RUGs IV 48 symptomatic VTE 48 oncologic outcomes 48 humoral responses 48 electromyographic 48 comorbid depression 48 multivariate analyzes 48 Pharmacodynamics 48 interindividual variability 48 pharmacological therapy 48 periprocedural 48 reactogenicity 48 histologically proven 48 % Confidence Interval 48 Cardiopulmonary bypass 48 Observational studies 48 abnormal cytology 48 hyperarousal 48 angiographically 48 ophthalmoscopy 48 cognitive behavioral therapies 48 plasma leptin 48 hemodynamic variables 48 radiographic findings 48 neuropathologic 48 sperm morphology 48 afterload 48 HbA 1C 48 discriminant 48 magnetic resonance spectroscopic imaging 48 neuromotor 48 serum estradiol 48 Mania Rating Scale 48 experimental allergic encephalomyelitis 48 metabolic dysfunction 48 psychiatric comorbidities 48 multiplicative 48 CHADS2 48 untreated psychosis 48 neurobiological basis 48 colorectal adenoma 48 Ashworth Scale 48 Kaplan Meier survival 48 HbA1C 48 catechol O methyltransferase 48 Total Nasal Symptom 47 depressive symptomatology 47 inflammatory biomarkers 47 multivariable adjustment 47 ovarian malignancy 47 pain catastrophizing 47 primary aldosteronism 47 PANSS total 47 Disease Activity 47 intravascular hemolysis 47 rearfoot 47 Clinical Relevance 47 florbetaben 47 hyper IgE syndrome 47 Somnolence 47 internalizing disorders 47 prognostic indicators 47 NMES 47 empirically derived 47 Picis Perioperative Dashboard 47 hemoperfusion 47 tumor histology 47 ‰ ¥ 47 symptom checklist 47 glycosylated hemoglobin HbA1c 47 polysomnography PSG 47 allostatic load 47 variance ANOVA 47 limiting generalizability 47 Histopathological 47 airway reactivity 47 Severity CGI S 47 prospectively enrolled 47 ADEAR Center 47 nonobstructive 47 hippocampal volumes 47 TROPOS 47 noncardiac 47 Beck Anxiety Inventory 47 neurodevelopmental outcome 47 psychiatric inpatients 47 confidence intervals CIs 47 endothelin antagonists 47 plethysmograph 47 diabetes mellitus DM 47 epoetin alpha 47 adenoma recurrence 47 postoperative complication 47 maternal fetal outcomes 47 hippocampal atrophy 47 prospective multicenter study 47 atherogenic dyslipidemia 47 mg BID dose 47 antipsychotic prescribing 47 Y BOCS 47 venlafaxine XR 47 acute subacute 47 somatic symptoms 47 viral kinetics 47 motivational interviewing 47 myocardial viability 47 transrectal ultrasound 47 genotype phenotype 47 sensory gating 47 chi ^ sup 47 postinjury 47 DCE MRI 47 renal cortical 47 functional gastrointestinal disorders 47 TNSS 47 SYNTAX trial 47 Regression analyzes 47 P = .# 47 abnormal lipid 47 clinico pathological 47 familial aggregation 47 airway responsiveness 47 Kruskal Wallis test 47 parasitological 47 EEG biofeedback 47 univariate 47 Cognitive Behavioural Therapy 47 Heritability 47 undergo percutaneous coronary 47 MMSE scores 47 genetic loci 47 EGFR mutation status 47 Socioeconomic status 47 Profile SEP 47 subclinical atherosclerosis 47 Change PGIC 47 cytologic 47 MCID 47 pain subscale 47 mRS 47 serologically active patients 47 retrospective cohort 47 renal allograft 47 Pharmacologic 47 antidiabetic medications 47 symptomatic hyponatremia 47 cardiometabolic risk 47 electroencephalographic EEG 47 VFQ 47 CC genotype 47 dyslipidaemia 47 chemosensitivity 47 neurodevelopmental outcomes 47 comorbid conditions 47 CYP#D# genotype 47 CAHPS 47 Cystatin C 47 Neuropsychological Status 47 serum lipids 47 clomipramine 47 Injury Severity Score 47 LDL HDL 47 actigraph 47 randomized controlled trials RCTs 47 CSF biomarkers 47 osteopathic manipulative treatment 47 decrements 47 Psychometric tests 47 visceral adiposity 47 Hemodynamic 47 Hb A1C 47 glycated hemoglobin HbA1c 47 FENO 47 HEDIS ® 47 cortical activation 47 sonographic diagnosis 47 neurocognitive impairment 47 neurologic outcomes 47 Inhibitory 47 metastatic lymph nodes 47 haematologic 47 intrapersonal 47 cerebellar vermis 47 inhibin B 47 IIEF 47 Bioavailability 47 aminotransferase 47 hypoactive 47 desvenlafaxine succinate 47 Electroencephalography 47 non pharmacological interventions 47 carotid ultrasound 47 cerebral oximetry 47 psychiatric comorbidity 47 mg Pycnogenol 47 Observable 47 glomerular filtration 47 bivariate analysis 47 Logistic Regression 47 vivo coagulation 47 cerebral perfusion 47 hippocampal volume 47 amygdala reactivity 47 histopathologic 47 linear regression analysis 47 HCAHPS survey 47 interpersonal psychotherapy 47 psychosocial 47 Phenotypic 47 polysomnography 47 Clinician Administered PTSD 47 neuro cognitive 47 HAMD 47 cerumen impaction 47 insulin sensitizing drug 47 thyroid carcinoma 47 KOOS 47 ionotropic 47 neurophysiological 47 psychopharmacologic 47 extracellular dopamine 47 indicates cardio circulatory 47 confirmed CCyR 47 Rating Scale IRLS 47 cognitive behavioral 47 Atomoxetine 47 ispinesib administered 47 urinary albumin excretion 47 obstetric ultrasound 47 lowest tertile 47 plasma adiponectin 47 IPAH 47 interpersonal psychotherapy IPT 47 binary logistic regression 47 prolactin levels 47 gonococcal 47 glycemic variability 47 pharmacologic treatments 47 parkinsonian symptoms 47 Capacity FVC 47 DQI 47 QTcF 47 Cardiac Resynchronization 47 aberrometer 47 pupil dilation 47 regression coefficient 47 pulse amplitude 47 OSAHS 47 clinicopathologic 47 underwent percutaneous coronary 47 Hill Rom enhancing 47 Brief Pain 47 AMOR IPAT 47 bone microarchitecture 47 prostaglandin analogues 46 FDG PET scans 46 frontostriatal 46 Scale EDSS score 46 maladaptive coping 46 % CI #.#-#.# [006] 46 statistically significant p 46 Systematic Treatment 46 impaired endothelial 46 somatoform disorders 46 macrovascular disease 46 transesophageal echocardiography 46 neural substrates 46 Standardised 46 bone scintigraphy 46 statistically nonsignificant 46 Cronbach 46 Erectile Function 46 immunohistochemical analysis 46 oral anticoagulation 46 covariance ANCOVA 46 microsimulation model 46 mammographic density 46 NIS LL 46 nephron sparing 46 Meta analyzes 46 sociodemographic 46 MSLT 46 nerve conduction velocity 46 Bipolar Disorder STEP BD 46 diabetic hypertensive 46 oculomotor 46 urate lowering 46 brachial artery flow 46 multivariable analyzes 46 fasting plasma glucose 46 hyperintensities 46 cerebral oxygen saturation 46 morbidity mortality 46 leukocytosis 46 stochastic resonance 46 VKORC1 46 total cholesterol HDL 46 psychobiological 46 Inventory BPI 46 bioelectrical impedance 46 prosocial behavior 46 hyperhomocysteinemia 46 euthyroid 46 Spirometry 46 meta cognitive 46 neurologic abnormalities 46 ± SD 46 prostate carcinogenesis 46 pharmacotherapeutic 46 Wechsler Memory 46 tumor subtype 46 AUCs 46 bivariate analyzes 46 striatal dopamine 46 Thrombolysis 46 somatization disorder 46 hyperinsulinemic euglycemic clamp 46 DAS# [002] 46 ejaculatory function 46 VCUG 46 STEP BD 46 spontaneous regression 46 socioeconomic variables 46 baroreflex sensitivity 46 -#.# mg dL [001] 46 STRATEGY FOR AN OPEN 46 DSM IV diagnoses 46 orofacial 46 quantitatively assess 46 Hemoglobin A1c 46 coronary calcification 46 #q# deletion 46 sensory acuity 46 Multivariate analyzes 46 cross sectionally 46 scientifically researched 46 triacylglycerol concentrations 46 anthropometry 46 preoperatively 46 Interrater reliability 46 patientsâ € ™ 46 carotid bruit 46 premenopause 46 ROC curves 46 serum bilirubin 46 Juvenile Idiopathic Arthritis 46 Myocardial 46 coagulation abnormalities 46 Efficacy endpoints 46 Myriad Flurizan 46 somatization 46 liver metastasis 46 ECLS 46 prefrontal cortical 46 KDOQI 46 Breslow thickness 46 PFAPA 46 hemodynamic parameters 46 Elastography 46 statistically significant 46 observable behaviors 46 semistructured interviews 46 Complicated Grief 46 oral antidiabetic medication 46 Nonverbal 46 periprocedural MI 46 ConclusionThis 46 observational cohort study 46 socio demographic 46 Nutritional Status 46 Affective 46 cerebellar 46 therapy CBT 46 elevated creatinine 46 Functional MRI 46 corneal astigmatism 46 chronic prostatitis chronic 46 dyspnoea 46 posttraumatic 46 neurologic dysfunction 46 Prefrontal 46 Zinc supplementation 46 syndromal 46 cortical atrophy 46 Persistent Sleep 46 self directedness 46 Index FSFI 46 Medication Adherence 46 cognitive domains 46 histopathological 46 Ultrasonographic 46 longitudinal cohort study 46 6MWT 46 Evaluable 46 Kaplan Meier analysis 46 intracerebral haemorrhage 46 glucocorticoid induced 46 coinfected patients 46 % CI #.#-#.# [007] 46 nonfasting 46 generalisability 46 Depression Rating Scale 46 Multivariate analysis 46 symptomatology 46 Kaplan Meier estimates 46 psychopharmacological 46 multivariate adjustment 46 orthostatic 46 cortex thickness 46 HbA 1c levels 46 Bayley Scales 46 patient centeredness 46 ShearWave Elastography 46 DAS# remission 46 PERMP 46 generalized linear

Back to home page